Clinical Trial Update: Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety, efficacy, and pharmacokinetics of recombinant FVIII Fc fusion protein in previously treated pediatric subjects with Hemophilia A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rFVIIIFc (recombinant factor VIII Fc fusion protein)

Snippet

Sponsor: Bioverativ Therapeutics Inc. | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2014-12-12